Extractive fermentation for enhanced production of thailandepsin A from Burkholderia thailandensis E264 using polyaromatic adsorbent resin Diaion HP-20

Journal of Industrial Microbiology and Biotechnology

Volumn 39, Issue 5, 2012, Pages 767-776

  Liu, Bing ^a   Hui, Junyuan ^a   Cheng, Yi Qiang ^b,c   Zhang, Xuehong ^a,c  

^a Shanghai Jiao Tong University   (China)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c Wuhan East Lake Hi Tech Development Zone   (China)

Author keywords

Burkholderia thailandensis E264; Central composite design; Extractive fermentation; Thailandepsin A

Indexed keywords

ANTINEOPLASTIC AGENT; CHLOROFORM; CITRATE SODIUM; GLUCOSE; HISTONE DEACETYLASE INHIBITOR; POTASSIUM DIHYDROGEN PHOSPHATE; RESIN; THAILANDEPSIN A; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; BIOMASS; BURKHOLDERIA; BURKHOLDERIA THAILANDENSIS; DRUG STRUCTURE; DRUG SYNTHESIS; EXTRACTIVE FERMENTATION; INCUBATION TIME; KINETICS; NEGATIVE FEEDBACK; NONHUMAN; PH; SOLVENT EXTRACTION;

ANTINEOPLASTIC AGENTS; BIOMASS; BURKHOLDERIA; DEPSIPEPTIDES; FERMENTATION; HISTONE DEACETYLASE INHIBITORS; KINETICS; PILOT PROJECTS; POLYSTYRENES;

BURKHOLDERIA THAILANDENSIS;

EID: 84863500295     PISSN: 13675435     EISSN: 14765535     Source Type: Journal    
DOI: 10.1007/s10295-011-1073-x     Document Type: Article

References (28)

1. Brett PJ, DeShazer D, Woods DE (1998) Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol 48:317-320 (Pubitemid 28144666)
2. Cheng Y-Q, Wang C (2011) Histone deacetylase inhibitors and used thereof. US patent application no. 20110060021 A1, 10 Mar 2011
3. du Preez JC, van Rensburg E, Kilian SG (2008) Kinetics of growth and leukotoxin production by Mannheimia haemolytica in continuous culture. J Ind Microbiol Biot 35(6):611-618. doi: 10.1007/s10295-008-0324-y
4. Haider MA, Pakshirajan K (2007) Screening and optimization of media constituents for enhancing lipolytic activity by a soil microorganism using statistically designed experiments. Appl Biochem Biotech 141(2-3):377-390
5. Hara M, Asano K, Kawamoto I, Takiguchi T, Katsumata S, Takahashi K, Nakano H (1989) Leinamycin, a new antitumor antibiotic from Streptomyces: producing organism, fermentation and isolation. J Antibiot (Tokyo) 42(12):1768-1774 (Pubitemid 20020844)
6. He L, Xu YQ, Zhang XH (2008) Medium factor optimization and fermentation kinetics for phenazine-1-carboxylic acid production by Pseudomonas sp. M18G. Biotechnol Bioeng 100(2):250-259. doi:10.1002/bit.21767 (Pubitemid 351758168)
7. Jia B, Jin ZH, Lei YL, Mei LH, Li NH (2006) Improved production of pristinamycin coupled with an adsorbent resin in fermentation by Streptomyces pristinaespiralis. Biotechnol Lett 28(22):1811-1815. doi:10.1007/s10529-006- 9157-9 (Pubitemid 44546726)
8. Lam KS, Gustavson DR, Veitch JA, Forenza S (1993) The effect of cerulenin on the production of esperamicin A1 by Actinomadura verrucosospora. J Ind Microbiol 12(2):99-102 (Pubitemid 23353217)
9. Lee JC, Park HR, Park DJ, Lee HB, Kim YB, Kim CJ (2003) Improved production of teicoplanin using adsorbent resin in fermentations. Lett Appl Microbiol 37(3):196-200. doi:10.1046/j.1472-765X.2003.01374.x (Pubitemid 37041214)
10. Lee JC, Park HR, Park SH, Park DJ, Lee HB, Kim YB, Kim CJ (2003) Improved production of teicoplanin using adsorbent resin in fermentations (vol 37, pg 195, 2003). Lett Appl Microbiol 37(4):360. doi:10.1046/j.1472-765X.2003.01404.x (Pubitemid 37186633)
11. Li Y, Jiang H, Xu Y, Zhang X (2008) Optimization of nutrient components for enhanced phenazine-1-carboxylic acid production by gacA-inactivated Pseudomonas sp. M18G using response surface method. Appl Microbiol Biotechnol 77(6):1207-1217. doi:10.1007/s00253-007-1213-4
12. Li YQ, Jiang HX, Du XL, Huang XQ, Zhang XH, Xu YH, Xu YQ (2010) Enhancement of phenazine-1-carboxylic acid production using batch and fed-batch culture of gacA inactivated Pseudomonas sp M18G. Bioresour Technol 101(10):3649-3656. doi: 10.1016/j.biortech.2009.12.120
13. Luedeking R, Piret E (1959) A kinetic study of the lactic acid fermentation: batch process at controlled pH. J Biochem Microbiol Technol Eng 1:393-431
14. Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R (2007) FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12(10):1247-1252. doi:10.1634/theoncologist.12-10-1247 (Pubitemid 350106355)
15. Marshall VP, McWethy SJ, Sirotti JM, Cialdella JI (1990) The effect of neutral resins on the fermentation production of rubradirin. J Ind Microbiol 5(5):283-287
16. Miller G (1959) Use of dinitrosalicylic acid reagent for the determination of reducing sugars. Anal Chem 31:426-428
17. Mundra P, Desai K, Lele SS (2007) Application of response surface methodology to cell immobilization for the production of palatinose. Bioresour Technol 98(15):2892-2896. doi:10.1016/j. biortech.2006.09.046 (Pubitemid 46628767)
18. Murthy MSRC, Swaminathan T, Rakshit SK, Kosugi Y (2000) Statistical optimization of lipase catalyzed hydrolysis of methyloleate by response surface methodology. Bioprocess Eng 22(1):35-39 (Pubitemid 30097243)
19. Nagata H, Ochiai K, Aotani Y, Ando K, Yoshida M, Takahashi I, Tamaoki T (1997) Lymphostin (LK6-A), a novel immunosuppressant from Streptomyces sp. KY11783: taxonomy of the producing organism, fermentation, isolation and biological activities. J Antibiot (Tokyo) 50(7):537-542 (Pubitemid 27376067)
20. Parawira W, Tekere M (2011) Biotechnological strategies to overcome inhibitors in lignocellulose hydrolysates for ethanolproduction: review. Crit Rev Biotechnol 31(1):20-31. doi: 10.3109/07388551003757816
21. Ping S (ed) (2000) Microbiology. Higher Education, Beijing
22. Sayyad SA, Panda BP, Javed S, Ali M (2007) Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Appl Microbiol Biotechnol 73(5):1054-1058. doi:10.1007/s00253-006-0577-1 (Pubitemid 44974313)
23. Singh MP, Leighton MM, Barbieri LR, Roll DM, Urbance SE, Hoshan L, McDonald LA (2010) Fermentative production of selftoxic fungal secondary metabolites. J Ind Microbiol Biotechnol 37(4):335-340. doi:10.1007/s10295-009- 0678-9
24. FDA (2010) StatBite: FDA oncology drug product approvals in 2009. J Natl Cancer Inst 102(4):219. doi:10.1093/jnci/djq030
25. Tanyildizi MS, Ozer D, Elibol M (2005) Optimization of alpha-amylase production by Bacillus sp using response surface methodology. Process Biochem 40(7):2291-2296. doi:10.1016/j.procbio.2004.06.018 (Pubitemid 40307377)
26. Tisma M, Sudar M, Vasic-Racki D, Zelic B (2010) Mathematical model for Trametes versicolor growth in submerged cultivation. Bioproc Biosyst Eng 33(6):749-758. doi:10.1007/s00449-009-0398-6
27. Vaiphei ST, Pandey G, Mukherjee KJ (2009) Kinetic studies of recombinant human interferon-gamma expression in continuous cultures of E. coli. J Ind Microbiol Biot 36(12):1453-1458. doi: 10.1007/s10295-009-0632-x
28. Wang C, Henkes LM, Doughty LB, He M, Wang D, Meyer-Almes FJ, ChengYQ(2011) Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities. J Nat Prod 74(10):2031-2038. doi: 10.1021/np200324x